CN113476551A - Magnetic liquid for treating insomnia and magnetic therapeutic device thereof - Google Patents

Magnetic liquid for treating insomnia and magnetic therapeutic device thereof Download PDF

Info

Publication number
CN113476551A
CN113476551A CN202110790028.XA CN202110790028A CN113476551A CN 113476551 A CN113476551 A CN 113476551A CN 202110790028 A CN202110790028 A CN 202110790028A CN 113476551 A CN113476551 A CN 113476551A
Authority
CN
China
Prior art keywords
liquid
magnetic therapy
magnetic
treating insomnia
magnetotherapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110790028.XA
Other languages
Chinese (zh)
Inventor
陈济世
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Jieping Hospital Management Co ltd
Original Assignee
Shanghai Jieping Hospital Management Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Jieping Hospital Management Co ltd filed Critical Shanghai Jieping Hospital Management Co ltd
Priority to CN202110790028.XA priority Critical patent/CN113476551A/en
Publication of CN113476551A publication Critical patent/CN113476551A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
    • A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
    • A61H39/007—Stimulation by mechanical vibrations, e.g. ultrasonic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/69—Polygalaceae (Milkwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8967—Lilium, e.g. tiger lily or Easter lily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biomedical Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Mechanical Engineering (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a magnetic therapy liquid for treating insomnia and a magnetic therapy device thereof, comprising the magnetic therapy liquid, plant essential oil, small molecular peptide, gamma aminobutyric acid, organic matter additive and water; the magnetic therapy liquid consists of neodymium iron boron magnetic powder, water and carbomer powder; the plant essential oil comprises extract of Ganoderma polysaccharide, semen Ziziphi Spinosae, Os Draconis, Cinnabaris, Ginseng radix, Poria, cortex et radix Polygalae, Bulbus Lilii, radix Acanthopanacis Senticosi, and fructus Schisandrae; the organic additive comprises melatonin, nicotinamide, laurylamine polyvinyl ether, propylene glycol, titanium dioxide, alcohol, triethanolamine, carbomer, isothiazolinone and silicone oil. The Nd-Fe-B permanent magnet acts on the human body to rectify the magnetic field of the human body and promote the meridian qi to run by enhancing the biological electromagnetic energy of the meridian of the human body, thereby achieving the treatment of dredging the meridian, increasing the blood and oxygen supply of the brain, reducing the excitability of the peripheral nerves of the cerebral cortex and insomnia.

Description

Magnetic liquid for treating insomnia and magnetic therapeutic device thereof
Technical Field
The invention relates to the technical field of insomnia adjuvant therapy, in particular to a magnetic therapy liquid for treating insomnia and a magnetic therapy device thereof.
Background
With the development of economic society, the pace of life is also continuously accelerated, and various pressures born by people are steadily increased, so that people are more prone to have insomnia, which means that people cannot fall asleep or keep a sleep state, and the sleep is insufficient. It is also called as sleep-in and sleep-maintaining disorder, and is a common disease caused by various reasons, such as difficulty in sleep-in, too short sleep depth or frequency, early awakening, insufficient sleep time or poor quality. Insomnia often brings great pain and psychological burden to patients, and damages other aspects of the body due to abuse of insomnia drugs. There are a number of ways to alleviate and treat insomnia.
The existing people widely adopt a magnetic therapy mode to treat insomnia so as to reduce the harm of medicine use to human bodies, but most of the conventional magnetic therapy treatments are magnetic mattresses and magnetic pillows, the functions are not obvious, the counterfeit function is easy to appear, the symptoms of insomnia patients cannot be effectively relieved, the head-wearing device has larger volume and is not convenient to carry, and the externally-applied magnetic therapy liquid for matching is lacked to improve the sleep-assisting effect, so that the magnetic therapy device for treating insomnia and the treatment liquid thereof are needed.
Disclosure of Invention
The invention aims to provide a magnetic therapy liquid for treating insomnia and a magnetic therapy device thereof, so as to solve the problems in the background technology.
The technical problem solved by the invention is realized by adopting the following technical scheme: a magnetotherapy liquid for treating insomnia comprises magnetotherapy liquid, plant essential oil, small molecule peptide, organic matter additive and water;
the magnetic therapy liquid consists of neodymium iron boron magnetic powder, water and carbomer powder;
the plant essential oil comprises extract of Ganoderma polysaccharide, semen Ziziphi Spinosae, Os Draconis, Cinnabaris, Ginseng radix, Poria, cortex et radix Polygalae, Bulbus Lilii, radix Acanthopanacis Senticosi, and fructus Schisandrae;
the organic additive comprises melatonin, gamma-aminobutyric acid, nicotinamide, laurylamine polyvinyl ether, propylene glycol, titanium dioxide, alcohol, triethanolamine, carbomer, isothiazolinone and silicone oil.
Further, 1 part of neodymium iron boron magnetic powder, 5 parts of glossy ganoderma polysaccharide, 10 parts of gamma aminobutyric acid, 3 parts of spina date seed, 11 parts of small molecular peptide, 0.1 part of keel powder, 0.1 part of cinnabar powder, 0.1 part of ginseng extraction essence, 0.1 part of poria cocos extraction essence, 0.1 part of polygala tenuifolia extraction essence, 0.1 part of lily extraction essence, 0.1 part of acanthopanax root extraction essence, 0.1 part of schisandra chinensis extraction essence, 11 parts of melatonin, 2 parts of nicotinamide, 1 part of laurylamine polyvinyl ether, 1 part of propylene glycol, 0.8 part of titanium dioxide, 10 parts of alcohol, 0.2-0.4 part of triethanolamine, 0.1-0.3 part of carbomer, 0.2-0.5 part of isothiazolinone, 0.005-0.015 part of silicone oil and 42 parts of water.
Further, the small molecule peptide comprises L-tryptophan.
Furthermore, the particle size of the neodymium iron boron magnetic powder after preparation is 10 mu m-0.2 mm.
Furthermore, the magnetic therapy liquid is filled into the magnetic therapy device, the magnetic therapy device comprises a liquid carrying device for storing the magnetic therapy liquid, a magnetic therapy head and a driving element, and the magnetic therapy head is a zinc alloy vibration head.
Further, still include the shell, the shell sets up top cap, middle section connecting shell, and middle section connecting shell passes through screw thread or buckle with the top cap and is connected, the lower extreme of carrying the liquid ware and middle section connecting shell passes through screw thread sealing connection.
Furthermore, the driving element comprises a lithium battery, a control circuit board, a control button and a vibration massage motor, and the vibration massage motor is connected with the magnetic therapy head.
Furthermore, an essence channel communicated with the liquid carrier is arranged in the magnetic therapy head.
Compared with the prior art, the invention has the following advantages: the invention provides a magnetic therapy liquid for adjuvant therapy of insomnia, which has the use characteristics of magnetic therapy and transdermal drug delivery, wherein a neodymium iron boron permanent magnet acts on a human body to correct the magnetic field of the human body per se, and promotes the meridian qi to run by enhancing the biological electromagnetic energy of the meridian of the human body, so that the purposes of dredging the meridian, increasing the blood and oxygen supply of a brain, reducing the excitability of peripheral nerves of a cerebral cortex, hypnotizing, and eliminating anxiety, neurasthenia and insomnia are achieved; transdermal administration: according to acupuncture and moxibustion and pharmacology of traditional Chinese medicine: the principle of external treatment of internal diseases. Meanwhile, a physical technical method is adopted. The natural active substances containing the sleep-aiding components are stored in the sleep gel and act on effective acupuncture points (limited to behind the ears, temples and halls) of a human body through the magnetic therapy device, and on one hand, the effective active substances enter a targeting position in the human body through the acupuncture points for supplying and repairing, so that the aim of aiding sleep is fulfilled. On the other hand, active substances in the magnetic therapy liquid stimulate acupuncture points to regulate the central nervous system of the brain responsible for sleeping through nerve reflection, so that the disordered central nervous system is continuously regulated and recovered, thereby regulating the sleeping and recovering the normal biological clock of a human.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings that are required to be used in the embodiments will be briefly described below, it should be understood that the following drawings only illustrate some embodiments of the present invention and therefore should not be considered as limiting the scope, and for those skilled in the art, other related drawings can be obtained according to the drawings without inventive efforts.
FIG. 1 is a schematic structural diagram of a magnetic therapeutic apparatus for treating insomnia according to the present invention;
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention more apparent, the technical solutions of the embodiments of the present invention will be described clearly and completely with reference to the accompanying drawings of the embodiments of the present invention, and it is obvious that the described embodiments are some, but not all embodiments of the present invention. All other embodiments, which can be obtained by a person skilled in the art without any inventive step based on the embodiments of the present invention, are within the scope of the present invention. Thus, the following detailed description of the embodiments of the present invention, presented in the figures, is not intended to limit the scope of the invention, as claimed, but is merely representative of selected embodiments of the invention.
Examples
A magnetic therapy liquid for treating insomnia is characterized in that: comprises magnetic therapy liquid, plant essential oil, small molecular peptide, organic matter additive and water;
the magnetic therapy liquid consists of neodymium iron boron magnetic powder, water and carbomer powder;
the plant essential oil comprises extract of Ganoderma polysaccharide, gamma-aminobutyric acid, semen Ziziphi Spinosae, Os Draconis, Cinnabaris, Ginseng radix, Poria, cortex et radix Polygalae, Bulbus Lilii, radix Acanthopanacis Senticosi, and fructus Schisandrae;
the organic additive comprises melatonin, nicotinamide, laurylamine polyvinyl ether, propylene glycol, titanium dioxide, alcohol, triethanolamine, carbomer, isothiazolinone and silicone oil.
The small molecule peptide comprises L-tryptophan.
The grain size of the neodymium iron boron magnetic powder is 10 mu m-0.2mm after preparation.
Wherein the magnetotherapy liquid comprises the following components in parts by weight: 1 part of neodymium iron boron magnetic powder, 5 parts of glossy ganoderma polysaccharide, 10 parts of gamma aminobutyric acid, 3 parts of spina date seed, 11 parts of small molecular peptide, 0.1 part of keel powder, 0.1 part of cinnabar powder, 0.1 part of ginseng extraction essence, 0.1 part of poria cocos extraction essence, 0.1 part of polygala tenuifolia extraction essence, 0.1 part of lily extraction essence, 0.1 part of acanthopanax extraction essence, 0.1 part of schisandra chinensis extraction essence, 11 parts of melatonin, 2 parts of nicotinamide, 1 part of laurylamine polyvinyl ether, 1 part of propylene glycol, 0.8 part of titanium dioxide, 10 parts of alcohol, 0.2-0.4 part of triethanolamine, 0.1-0.3 part of carbomer, 0.2-0.5 part of isothiazolinone, 0.005-0.015 part of silicone oil and 42 parts of water.
The following table lists the names and weight ratios of the components and the corresponding effects of the components
Figure BDA0003160519130000051
Figure BDA0003160519130000061
Figure BDA0003160519130000071
The magnetotherapy liquid is filled into the magnetotherapy device, and the back of the ear, the temple and the acupoint corresponding to Yintang are massaged by vibration massage,
the utility model provides a magnetotherapy ware is including the carrier liquid ware 5 that is used for storing magnetotherapy liquid, magnetotherapy head 2 and drive element 3, magnetotherapy head is zinc alloy vibrations head, still include the shell, the shell sets up top cap 1, middle section connecting shell 6, and middle section connecting shell 6 passes through screw thread or buckle with top cap 1 and is connected, carrier liquid ware 5 passes through thread sealing with the lower extreme of middle section connecting shell 6, drive element 3 includes the lithium cell, a control circuit board, control button and vibrations massage motor, vibrations massage motor is connected with magnetotherapy head 2, the overhead essence passageway 4 that communicates with carrier liquid ware that is provided with of magnetotherapy.
In the implementation process, the lithium battery in the driving element 3 can also be externally provided with a corresponding charging interface to realize long-term practicability, the control circuit board is provided with a control circuit to adjust the working transmission power of the vibration massage motor to realize multi-gear adjustment, and the control button is utilized to realize on-off adjustment.
In the use, magnetic therapy liquid is stored in the liquid carrying device 5, the vibration massage motor is controlled by the adjusting control button to drive the magnetic therapy head 2 to vibrate, the magnetic therapy liquid flows out from the top end of the magnetic therapy head 2 through the essence channel 4, the top of the magnetic therapy head 2 is set to be a smooth arc surface to be in contact with corresponding acupuncture points for vibration massage, the magnetic therapy head 2 is selected to be a zinc alloy vibration head which is not easy to corrode and does not have anaphylactic reaction when being in contact with the skin of most people, and the metal head is more beneficial to smearing the magnetic therapy liquid to help promote the absorption of the human body to the magnetic therapy liquid
The foregoing shows and describes the general principles, essential features, and advantages of the invention. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, which are described in the specification and illustrated only to illustrate the principle of the present invention, but that various changes and modifications may be made therein without departing from the spirit and scope of the present invention, which fall within the scope of the invention as claimed. The scope of the invention is defined by the appended claims and equivalents thereof.

Claims (8)

1. A magnetic therapy liquid for treating insomnia is characterized in that: comprises magnetic therapy liquid, plant essential oil, small molecular peptide, gamma aminobutyric acid, organic matter additive and water;
the magnetic therapy liquid consists of neodymium iron boron magnetic powder, water and carbomer powder;
the plant essential oil comprises extract of Ganoderma polysaccharide, semen Ziziphi Spinosae, Os Draconis, Cinnabaris, Ginseng radix, Poria, cortex et radix Polygalae, Bulbus Lilii, radix Acanthopanacis Senticosi, and fructus Schisandrae;
the organic additive comprises melatonin, nicotinamide, laurylamine polyvinyl ether, propylene glycol, titanium dioxide, alcohol, triethanolamine, carbomer, isothiazolinone and silicone oil.
2. The magnetotherapeutic liquid for treating insomnia according to claim 1, wherein the magnetotherapeutic liquid formula comprises, by weight: neodymium iron boron magnetic powder 1, glossy ganoderma polysaccharide 5, gamma aminobutyric acid 10, spina date seed 3, small molecular peptide 11, keel powder 0.1, cinnabar powder 0.1, ginseng extract 0.1, poria extract 0.1, polygala extract 0.1, lily extract 0.1, acanthopanax extract 0.1, schisandra extract 0.1, melatonin 11, nicotinamide 2, laurylamine polyvinyl ether 1, propylene glycol 1, titanium dioxide 0.8, alcohol 10, triethanolamine 0.2-0.4, carbomer 0.1-0.3, isothiazolinone 0.2-0.5, silicone oil 0.005-0.015 and water 42.
3. The magnetotherapeutic solution for treating insomnia according to claim 1, wherein the small molecule peptide includes L-tryptophan.
4. The magnetotherapeutic liquid for treating insomnia according to claim 1, wherein the prepared neodymium-iron-boron magnetic powder has a particle size of 10 μm to 0.2 mm.
5. The magnetotherapeutic liquid for treating insomnia according to any one of claims 1 to 4, wherein: the magnetic therapy liquid is filled into the magnetic therapy device, the magnetic therapy device comprises a liquid carrying device for storing the magnetic therapy liquid, a magnetic therapy head and a driving element, and the magnetic therapy head is a zinc alloy vibration head.
6. The magnetotherapeutic device for treating insomnia according to claim 5, wherein: the liquid carrying device is characterized by further comprising a shell, the shell is provided with a top cover and a middle connecting shell, the middle connecting shell is connected with the top cover through threads or buckles, and the liquid carrying device is connected with the lower end of the middle connecting shell in a sealing mode through threads.
7. The magnetotherapeutic device for treating insomnia according to claim 5, wherein: the driving element comprises a lithium battery, a control circuit board, a control button and a vibration massage motor, and the vibration massage motor is connected with the magnetic therapy head.
8. The magnetotherapeutic device for treating insomnia according to claim 5, wherein: an essence channel communicated with the liquid carrier is arranged in the magnetic therapy head.
CN202110790028.XA 2021-07-13 2021-07-13 Magnetic liquid for treating insomnia and magnetic therapeutic device thereof Pending CN113476551A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110790028.XA CN113476551A (en) 2021-07-13 2021-07-13 Magnetic liquid for treating insomnia and magnetic therapeutic device thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110790028.XA CN113476551A (en) 2021-07-13 2021-07-13 Magnetic liquid for treating insomnia and magnetic therapeutic device thereof

Publications (1)

Publication Number Publication Date
CN113476551A true CN113476551A (en) 2021-10-08

Family

ID=77938386

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110790028.XA Pending CN113476551A (en) 2021-07-13 2021-07-13 Magnetic liquid for treating insomnia and magnetic therapeutic device thereof

Country Status (1)

Country Link
CN (1) CN113476551A (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2587431Y (en) * 2002-12-12 2003-11-26 郑州市科学技术局 Health care beautifying apparatus with whitening and dirt suction function
CN2691583Y (en) * 2004-05-09 2005-04-13 李哲 Magnetic therapy massage pen
CN101214190A (en) * 2007-01-04 2008-07-09 张领然 Massaging magnetic therapy magnetizing coating beautifying health care therapeutic equipment
CN203123346U (en) * 2013-03-14 2013-08-14 吉林省佳美生物科技开发有限公司 Body-building health-care physiotherapy instrument
CN107737331A (en) * 2017-11-20 2018-02-27 中食都庆（山东）生物技术有限公司 A kind of compound product with tranquilizing effect and preparation method thereof
CN208446840U (en) * 2018-04-25 2019-02-01 深圳市格比科技有限公司 A kind of new type of cosmetic pen
CN111195333A (en) * 2020-01-07 2020-05-26 广州市白云区天芳化妆品厂 Composition and sleep cream for improving sleep, and preparation method and use method thereof
CN112056482A (en) * 2020-10-13 2020-12-11 广州小象健康产业有限公司 Sleep-aiding small-molecule peptide solid beverage and preparation method and application thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2587431Y (en) * 2002-12-12 2003-11-26 郑州市科学技术局 Health care beautifying apparatus with whitening and dirt suction function
CN2691583Y (en) * 2004-05-09 2005-04-13 李哲 Magnetic therapy massage pen
CN101214190A (en) * 2007-01-04 2008-07-09 张领然 Massaging magnetic therapy magnetizing coating beautifying health care therapeutic equipment
CN203123346U (en) * 2013-03-14 2013-08-14 吉林省佳美生物科技开发有限公司 Body-building health-care physiotherapy instrument
CN107737331A (en) * 2017-11-20 2018-02-27 中食都庆（山东）生物技术有限公司 A kind of compound product with tranquilizing effect and preparation method thereof
CN208446840U (en) * 2018-04-25 2019-02-01 深圳市格比科技有限公司 A kind of new type of cosmetic pen
CN111195333A (en) * 2020-01-07 2020-05-26 广州市白云区天芳化妆品厂 Composition and sleep cream for improving sleep, and preparation method and use method thereof
CN112056482A (en) * 2020-10-13 2020-12-11 广州小象健康产业有限公司 Sleep-aiding small-molecule peptide solid beverage and preparation method and application thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
李国祥等: "中西医结合治疗共病焦虑抑郁慢性失眠患者的临床研究", 《世界中西医结合杂志》 *
袁野: "《知己健康手册经络篇》", 30 November 2016, 中医古籍出版社 *
陈文珍: "芝宁多糖治失眠确实有效吗", 《有来医生》 *
陈选宁等: "《颈椎病康复指南》", 31 May 2012, 湖北科学技术出版社 *

Similar Documents

Publication Publication Date Title
US20060167526A1 (en) Medical apparatus and system for preventing and treating diseases
CN101904944B (en) Male silkworm health care wine and preparation method thereof
CN109303975A (en) Multifunctional eye drug introducing apparatus
CN113476551A (en) Magnetic liquid for treating insomnia and magnetic therapeutic device thereof
CN102988127A (en) Manual cervical traction massager
CN207837858U (en) A kind of tranquilizing the mind ring for treating insomnia
CN2902239Y (en) Eye-shield for treating eyes with traditional Chinese medicine
CN205019379U (en) Head, neck massager
CN213373729U (en) Warm moxibustion device for treating chronic atrophic gastritis
CN105311400A (en) Formula for treating unclear vision due to kidney-yin deficiency
CN203987227U (en) A kind of pillow with neck with three-dimensional ear groove
CN213219076U (en) Massage finger ring
CN215690359U (en) Cupping device for eye sleeve of human body
CN2815344Y (en) Self-help waist-buttocks quick-acting massager
CN202198972U (en) Cap with intelligence-improving and brain-invigorating functions
CN102671301A (en) System for comprehensively relaxing eyeballs after visual training
CN105998933A (en) Traditional Chinese medicine composition for treating neurasthenia
CN1081871A (en) Magnetic physiotherapeutic needle
CN2512258Y (en) Far infrared medicinal magnetic health socks
CN101371813A (en) Automatic massaging pillow
CN2582652Y (en) Magnetic therapy device for treating cranial nerve diseases
Wen et al. Clinical experience of Professor Shao Jing-ming: a master of acupuncture-moxibustion
CN1274374C (en) Magnetic-needle negative-pressure LF physiotherapeutic instrument
Yimin Meridian and Collateral Holistic Therapy and Middle-Age Repair
TWM648006U (en) Terahertz functional pillow that can support head and neck and maintain smooth blood flow

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20211008

RJ01 Rejection of invention patent application after publication